CXCL10 and neoplasm: Increasing CXCL10 levels or enhancing signaling through CXCR3 receptors can boost the immune response by recruiting cytotoxic ‎T cells ‎and NK cells, which are critical for cancer cell clearance.73 This makes CXCL10 ‎a valuable target ‎in cancer immunotherapy, as therapies that enhance its expression could ‎increase anti-tumor ‎immune activity.